Developing tailored immunization materials for concerned mothers.
The objectives of this study were to (i) identify 'Worried' and 'Fencesitter' mothers through the use of screening questions; (ii) obtain detailed information from participants about their attitudes and beliefs regarding vaccines and their interactions with their child's main health care provider, including availability of immunization information; (iii) solicit comments on draft educational materials that were developed specifically for this study and (iv) solicit comments on revised educational materials. Focus groups of mothers were conducted in two phases (Phase 1: n = 17 groups; Phase 2: n = 12 groups) and in three cities across the United States. Phase 1 focus group discussions suggested that perceived necessity and safety of vaccines contributed to mothers' attitudes about having their child receive immunizations. Participants relied on their children's main health care provider for immunization information; however, mothers often perceived that providers did not supply enough information about vaccinations. In Phase 2, comments on the revised educational materials (brochures) were generally positive, with many mothers noting that the new brochures provided more relevant information and conveyed it in a respectful way. Science-based tailored immunization materials may assist health care providers in addressing unique information needs and may improve vaccine acceptance among specific types of mothers.
Gust
Deborah A
DA
Centers for Disease Control.revention, 1600 Clifton Road, Mailstop E-52, Atlanta, GA 30333, USA. dgg6@cdc.gov
Kennedy
Allison
A
Wolfe
Skip
S
Sheedy
Kris
K
Nguyen
Chau
C
Campbell
Scott
S
D000328:Adult; D004347:Drug Interactions; D005260:Female; D006266:Health Education / Q000379:methods*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008875:Middle Aged; D009035:Mothers / Q000523:psychology*; D012959:Socioeconomic Factors; D014612:Vaccines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D014612:Vaccines